Agios Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$1.97 | -$1.28 | -$1.65 |
| Q2 2024 | 2 | -$1.91 | -$1.24 | -$1.60 |
| Q3 2024 | 2 | $11.82 | $18.19 | $15.22 |
| Q4 2024 | 7 | -$1.89 | -$1.57 | -$1.67 |
| Q1 2025 | 4 | -$1.71 | -$1.56 | -$1.63 |
| Q2 2025 | 2 | -$2.02 | -$1.31 | -$1.69 |
| Q3 2025 | 2 | -$1.99 | -$1.30 | -$1.67 |
| Q4 2025 | 2 | -$1.65 | -$1.07 | -$1.38 |
Agios Pharmaceuticals, Inc. Earnings Date And Information
Agios Pharmaceuticals, Inc. last posted its earnings results on Thursday, October 31st, 2024. The company reported $4.2 earnings per share for the quarter, missing analysts' consensus estimates of $16.69 by $12.49. The company had revenue of 8.96 M for the quarter and had revenue of 26.82 M for the year. Agios Pharmaceuticals, Inc. has generated $-6 earnings per share over the last year ($-6.33 diluted earnings per share) and currently has a price-to-earnings ratio of 3.94. Agios Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based on prior year's report dates.
Agios Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/31/2024 | Q3 2024 | $16.69 | $16.65 | -0.04 | $9.44 M | $8.96 M |
| 08/01/2024 | Q2 2024 | -$1.58 | -$1.69 | -0.11 | $9.34 M | $8.62 M |
| 05/02/2024 | Q1 2024 | -$1.64 | -$1.45 | 0.19 | $8.19 M | |
| 02/15/2024 | Q4 2023 | -$1.64 | -$1.72 | -0.08 | $7.10 M | |
| 11/02/2023 | Q3 2023 | -$1.69 | -$1.64 | 0.05 | $7.53 M | $7.40 M |
| 08/03/2023 | Q2 2023 | -$1.60 | -$1.51 | 0.09 | $6.46 M | $6.71 M |
| 05/04/2023 | Q1 2023 | -$1.72 | -$1.30 | 0.42 | $5.61 M | |
| 02/23/2023 | Q4 2022 | -$1.59 | $3.14 | 4.73 | $4.31 M | |
| 11/03/2022 | Q3 2022 | -$1.75 | -$1.32 | 0.43 | $5.27 M | $3.52 M |
| 08/04/2022 | Q2 2022 | -$1.78 | -$1.68 | 0.1 | $2.91 M | $5.58 M |
| 05/05/2022 | Q1 2022 | -$1.85 | -$1.62 | 0.23 | $832,000 | |
| 02/24/2022 | Q4 2021 | -$1.71 | -$1.74 | -0.03 | $0 | |
| 11/03/2021 | Q3 2021 | -$1.61 | -$1.56 | 0.05 | $2.55 M | $0 |
| 07/29/2021 | Q2 2021 | -$1.39 | -$1.41 | -0.02 | $2.49 M | $37.35 M |
| 04/29/2021 | Q1 2021 | -$1.23 | $26.95 | 28.18 | $41.41 M | |
| 02/25/2021 | Q4 2020 | -$1.41 | -$1.41 | 0 | $44.05 M | |
| 11/05/2020 | Q3 2020 | -$1.40 | -$1.43 | -0.03 | $38.12 M | $34.71 M |
| 07/30/2020 | Q2 2020 | -$1.42 | -$1.31 | 0.11 | $37.14 M | $37.35 M |
| 04/30/2020 | Q1 2020 | -$1.70 | -$0.59 | 1.11 | $87.10 M | |
| 02/19/2020 | Q4 2019 | -$1.60 | $35.44 M |
Agios Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Agios Pharmaceuticals, Inc.'s earnings date?
Agios Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based off last year's report dates.
-
How can I listen to Agios Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Agios Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Agios Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Agios Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does Agios Pharmaceuticals, Inc. generate each year?
Agios Pharmaceuticals, Inc. (:AGIO) has a recorded annual revenue of $26.82 M.
-
How much profit does Agios Pharmaceuticals, Inc. generate each year?
Agios Pharmaceuticals, Inc. (:AGIO) has a recorded net income of $26.82 M. Agios Pharmaceuticals, Inc. has generated $-6.33 earnings per share over the last four quarters.
-
What is Agios Pharmaceuticals, Inc.'s price-to-earnings ratio?
Agios Pharmaceuticals, Inc. (:AGIO) has a price-to-earnings ratio of 3.94 and price/earnings-to-growth ratio is 0.01.
